VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials - Concepedia

Concepedia

Publication | Closed Access

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials

186

Citations

26

References

2012

Year

Diether Lambrechts, Bart Claes, Paul Delmar, Joke Reumers, Massimiliano Mazzone, Betül T. Yesilyurt, Roland Devlieger, Chris Verslype, Sabine Tejpar, Hans Wildiers,

The Lancet Oncology

Genetic VariantsTreatment OutcomeAngiogenesisNovel TherapyMedicineGenetic EpidemiologyImmunologyPathologyVascular BiologyMolecular DiagnosticsTumor MicroenvironmentMolecular Medicine

References

	Year	Citations

Page 1

Page 1